Abstract:Bone is a biomechanical tissue shaped by forces from muscles and gravitation. Simultaneous bone and muscle decay and dysfunction (osteosarcopenia or sarco-osteoporosis) is seen in ageing, numerous clinical situations including after stroke or paralysis, in neuromuscular dystrophies, glucocorticoid excess, or in association with vitamin D, growth hormone/insulin like growth factor or sex steroid deficiency, as well as in spaceflight. Physical exercise may be beneficial in these situations, but further work is still needed to translate acceptable and effective biomechanical interventions like vibration therapy from animal models to humans. Novel antiresorptive and anabolic therapies are emerging for osteoporosis as well as drugs for sarcopenia, cancer cachexia or muscle wasting disorders, including antibodies against myostatin or activin receptor type IIA and IIB (e.g. bimagrumab). Ideally, increasing muscle mass would increase muscle strength and restore bone loss from disuse. However, the classical view that muscle is unidirectionally dominant over bone via mechanical loading is overly simplistic. Indeed, recent studies indicate a role for neuronal regulation of not only muscle but also bone metabolism, bone signaling pathways like receptor activator of nuclear factor kappa-B ligand (RANKL) implicated in muscle biology, myokines affecting bone and possible bone-to-muscle communication. Moreover, pharmacological strategies inducing isolated myocyte hypertrophy may not translate into increased muscle power because tendons, connective tissue, neurons and energy metabolism need to adapt as well. We aim here to critically review key musculoskeletal molecular pathways involved in mechanoregulation and their effect on the bone-muscle unit as a whole, as well as preclinical and emerging clinical evidence regarding the effects of sarcopenia therapies on osteoporosis and vice versa.

Muscle physiology and its relations to the whole body in health and disease

Myokines mediate the cross talk between skeletal muscle and other organs

Muscle-Organ Crosstalk: The Emerging Roles of Myokines

Skeletal muscle: A review of molecular structure and function, in health and disease

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease

Advances in Muscle Research in Health and Disease

Innovations in the Assessment of Skeletal Muscle Health: A Glimpse into the Future

Muscle Wasting Diseases: Novel Targets and Treatments

Skeletal Muscle Extracellular Matrix – What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review

Muscle-bone interactions: From experimental models to the clinic? A critical update

Mass spectrometry‐based proteomics approaches to interrogate skeletal muscle adaptations to exercise

[Paracrine and endocrine functions of muscles]

Mitochondrial Adaptation in Skeletal Muscle: Impact of Obesity, Caloric Restriction, and Dietary Compounds

The application of proteomics in muscle exercise physiology

The role of exercise-induced myokines in regulating metabolism

Advances in muscle health and nutrition: A toolkit for healthcare professionals

Skeletal muscle as a pro- and anti-inflammatory tissue: insights from children to adults and ultrasound findings

The molecular athlete: exercise physiology from mechanisms to medals

Skeletal muscle mitochondrial remodeling in exercise and diseases

The inflammatory response, a mixed blessing for muscle homeostasis and plasticity

Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise